INT184894

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.47
First Reported 2005
Last Reported 2010
Negated 3
Speculated 0
Reported most in Body
Documents 9
Total Number 9
Disease Relevance 10.04
Pain Relevance 3.31

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleoplasm (MCRS1) protein modification process (MCRS1) nucleolus (MCRS1)
nucleus (MCRS1) cytoplasm (MCRS1)
Anatomy Link Frequency
cerebrospinal fluid 2
MCRS1 (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 938 100.00 Very High Very High Very High
intrathecal 1 99.04 Very High Very High Very High
ischemia 17 74.12 Quite High
dexamethasone 3 70.40 Quite High
Pain 5 38.88 Quite Low
Analgesic 1 38.68 Quite Low
Sumatriptan 1 37.76 Quite Low
Migraine 3 35.72 Quite Low
Inflammatory mediators 2 29.76 Quite Low
headache 3 13.76 Low Low
Disease Link Frequency Relevance Heat
Cv General 3 Under Development 689 100.00 Very High Very High Very High
Death 113 100.00 Very High Very High Very High
Acute Coronary Syndrome 56 98.22 Very High Very High Very High
Altitude Sickness 39 96.12 Very High Very High Very High
Hydrocephalus 20 95.44 Very High Very High Very High
Brain Injury 88 91.28 High High
Coma 30 91.12 High High
Cv General 4 Under Development 243 90.40 High High
Aneurism 23 89.92 High High
Heart Disease 4 89.20 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
ONSD values are relative and not calibrated to actual ICP.
Neg (not) Localization (calibrated) of ICP associated with cva
1) Confidence 0.47 Published 2010 Journal BMC Neurol Section Body Doc Link PMC2987855 Disease Relevance 0.73 Pain Relevance 0.26
The residuals used in the logistic models for ICP, HD and EHR were, at a regional level, the signed deviance residuals, given by:

where y is the number of observed event (ICP, HD or EHR) in the region and ?

Localization (used) of ICP associated with death
2) Confidence 0.34 Published 2005 Journal BMC Cardiovasc Disord Section Body Doc Link PMC1181243 Disease Relevance 0.43 Pain Relevance 0
If the care for ACS was delivered over several contiguous hospitalizations involving hospital transfer, the presence of an ICP, HD and the LoS were evaluated for the entire episode.
Localization (presence) of ICP associated with acute coronary syndrome and death
3) Confidence 0.34 Published 2005 Journal BMC Cardiovasc Disord Section Body Doc Link PMC1181243 Disease Relevance 0.66 Pain Relevance 0
When there is no relationship between MAP and ICP, increasing MAP typically will not increase ICP [15,22,23] Thus, when the CAP Index is increased and ICP cannot be reduced, increasing MAP may improve CPP.
Neg (no) Localization (relationship) of ICP associated with cva
4) Confidence 0.31 Published 2006 Journal Crit Care Section Body Doc Link PMC1794465 Disease Relevance 1.26 Pain Relevance 0.50
When the CAP Index is >0.25 (n = 365; MAP - 91.0 ± 12.0; ICP - 27.1 ± 9.1; CPP - 64.0 ± 14.6), there is no relationship between MAP and ICP (r = 0.07; p = 0.16)

Discussion

Neg (no) Localization (relationship) of ICP associated with cva
5) Confidence 0.31 Published 2006 Journal Crit Care Section Body Doc Link PMC1794465 Disease Relevance 1.28 Pain Relevance 0.56
Surviving patients have decreased ICP, increased CPP, decreased CAP Index, increased StcO2, and increased BIS.
Localization (decreased) of ICP associated with cva
6) Confidence 0.27 Published 2006 Journal Crit Care Section Body Doc Link PMC1794465 Disease Relevance 1.13 Pain Relevance 0.54
In summary, after recognition and treatment of the origins of the patient’s poor condition, additional factors associated with ischemic condition (increased ICP, decreased CPP, and damaged autoregulation) still need to be monitored.
Localization (decreased) of ICP associated with cva
7) Confidence 0.04 Published 2007 Journal Vascular Health and Risk Management Section Body Doc Link PMC2350130 Disease Relevance 0.57 Pain Relevance 0.16
This technique allows for rapid clearance of cerebrospinal fluid, release of ICP, and ICP/CPP monitoring.
Localization (release) of ICP in cerebrospinal fluid associated with cva
8) Confidence 0.02 Published 2008 Journal Crit Care Section Body Doc Link PMC2646334 Disease Relevance 1.98 Pain Relevance 0.64
This technique allows for rapid clearance of cerebrospinal fluid, release of ICP, and ICP/CPP monitoring.
Localization (release) of ICP in cerebrospinal fluid associated with cva
9) Confidence 0.01 Published 2008 Journal Crit Care Section Body Doc Link PMC2646334 Disease Relevance 1.99 Pain Relevance 0.64

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox